APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tissue and Organ Transplantation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tissue and Organ Transplantation Market Outlook and Growth Opportunities 2026

Report ID 174041480430 December 2025197 pages

Choose your research edition.

Industry ResearchTissue and Organ Transplantation Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Tissue and Organ Transplantation Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tissue and Organ Transplantation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tissue and Organ Transplantation Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Tissue and Organ Transplantation Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Tissue and Organ Transplantation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tissue and Organ Transplantation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tissue and Organ Transplantation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tissue and Organ Transplantation market include Arthrex, Biolife Solutions, Discovery Life Sciences, Medtronic, Stryker Corporation, Teva Pharmaceuticals, Veloxis Pharmaceutical, Zimmer Biomet and Abbvie, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Tissue and Organ Transplantation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tissue and Organ Transplantation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tissue and Organ Transplantation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Tissue and Organ Transplantation market.

Tissue and Organ Transplantation Segment by Company

Arthrex

Biolife Solutions

Discovery Life Sciences

Medtronic

Stryker Corporation

Teva Pharmaceuticals

Veloxis Pharmaceutical

Zimmer Biomet

Abbvie

Novartis

Tissue and Organ Transplantation Segment by Type

Preservation Solution

Immunosuppressive Drugs

Tissue Products

Tissue and Organ Transplantation Segment by Application

Hospital

Transplant Centers

Others

Tissue and Organ Transplantation Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Tissue and Organ Transplantation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Tissue and Organ Transplantation key companies, revenue, market share, and recent developments.

3. To split the Tissue and Organ Transplantation breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Tissue and Organ Transplantation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tissue and Organ Transplantation significant trends, drivers, influence factors in global and regions.

6. To analyze Tissue and Organ Transplantation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue and Organ Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tissue and Organ Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue and Organ Transplantation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tissue and Organ Transplantation industry.

Chapter 3: Detailed analysis of Tissue and Organ Transplantation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Tissue and Organ Transplantation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Tissue and Organ Transplantation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tissue and Organ Transplantation Industry Trends Table 2. Tissue and Organ Transplantation Industry Drivers Table 3. Tissue and Organ Transplantation Industry Opportunities and Challenges Table 4. Tissue and Organ Transplantation Industry Restraints Table 5. Global Tissue and Organ Transplantation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tissue and Organ Transplantation Revenue Share by Company (2021-2026) Table 7. Global Tissue and Organ Transplantation Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Tissue and Organ Transplantation Key Company Manufacturing Base & Headquarters Table 9. Global Tissue and Organ Transplantation Company, Product Type & Application Table 10. Global Tissue and Organ Transplantation Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Tissue and Organ Transplantation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Preservation Solution Table 15. Significant Companies of Immunosuppressive Drugs Table 16. Significant Companies of Tissue Products Table 17. Global Tissue and Organ Transplantation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Tissue and Organ Transplantation Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Tissue and Organ Transplantation Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Tissue and Organ Transplantation Sales Value Share by Type (2021-2026) Table 21. Global Tissue and Organ Transplantation Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Transplant Centers Table 24. Significant Companies of Others Table 25. Global Tissue and Organ Transplantation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Tissue and Organ Transplantation Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Tissue and Organ Transplantation Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Tissue and Organ Transplantation Sales Value Share by Application (2021-2026) Table 29. Global Tissue and Organ Transplantation Sales Value Share by Application (2027-2032) Table 30. Global Tissue and Organ Transplantation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Tissue and Organ Transplantation Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Tissue and Organ Transplantation Sales Value Share by Region (2021-2026) Table 33. Global Tissue and Organ Transplantation Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Tissue and Organ Transplantation Sales Value Share by Region (2027-2032) Table 35. Global Tissue and Organ Transplantation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Tissue and Organ Transplantation Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Tissue and Organ Transplantation Sales Value Market Share by Country (2021-2026) Table 38. Global Tissue and Organ Transplantation Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Tissue and Organ Transplantation Sales Value Market Share by Country (2027-2032) Table 40. Arthrex Company Information Table 41. Arthrex Business Overview Table 42. Arthrex Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Arthrex Tissue and Organ Transplantation Product Portfolio Table 44. Arthrex Recent Development Table 45. Biolife Solutions Company Information Table 46. Biolife Solutions Business Overview Table 47. Biolife Solutions Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Biolife Solutions Tissue and Organ Transplantation Product Portfolio Table 49. Biolife Solutions Recent Development Table 50. Discovery Life Sciences Company Information Table 51. Discovery Life Sciences Business Overview Table 52. Discovery Life Sciences Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio Table 54. Discovery Life Sciences Recent Development Table 55. Medtronic Company Information Table 56. Medtronic Business Overview Table 57. Medtronic Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Medtronic Tissue and Organ Transplantation Product Portfolio Table 59. Medtronic Recent Development Table 60. Stryker Corporation Company Information Table 61. Stryker Corporation Business Overview Table 62. Stryker Corporation Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Stryker Corporation Tissue and Organ Transplantation Product Portfolio Table 64. Stryker Corporation Recent Development Table 65. Teva Pharmaceuticals Company Information Table 66. Teva Pharmaceuticals Business Overview Table 67. Teva Pharmaceuticals Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio Table 69. Teva Pharmaceuticals Recent Development Table 70. Veloxis Pharmaceutical Company Information Table 71. Veloxis Pharmaceutical Business Overview Table 72. Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio Table 74. Veloxis Pharmaceutical Recent Development Table 75. Zimmer Biomet Company Information Table 76. Zimmer Biomet Business Overview Table 77. Zimmer Biomet Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Zimmer Biomet Tissue and Organ Transplantation Product Portfolio Table 79. Zimmer Biomet Recent Development Table 80. Abbvie Company Information Table 81. Abbvie Business Overview Table 82. Abbvie Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Abbvie Tissue and Organ Transplantation Product Portfolio Table 84. Abbvie Recent Development Table 85. Novartis Company Information Table 86. Novartis Business Overview Table 87. Novartis Tissue and Organ Transplantation Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Novartis Tissue and Organ Transplantation Product Portfolio Table 89. Novartis Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Tissue and Organ Transplantation Product Image Figure 2. Global Tissue and Organ Transplantation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tissue and Organ Transplantation Market Size (2021-2032) & (US$ Million) Figure 4. Global Tissue and Organ Transplantation Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Preservation Solution Image Figure 8. Immunosuppressive Drugs Image Figure 9. Tissue Products Image Figure 10. Global Tissue and Organ Transplantation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Tissue and Organ Transplantation Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Tissue and Organ Transplantation Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Transplant Centers Image Figure 15. Others Image Figure 16. Global Tissue and Organ Transplantation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Tissue and Organ Transplantation Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Tissue and Organ Transplantation Sales Value Share by Application (2021-2032) Figure 19. Global Tissue and Organ Transplantation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Tissue and Organ Transplantation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Tissue and Organ Transplantation Sales Value (2021-2032) & (US$ Million) Figure 22. North America Tissue and Organ Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Tissue and Organ Transplantation Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Tissue and Organ Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Tissue and Organ Transplantation Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Tissue and Organ Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Tissue and Organ Transplantation Sales Value (2021-2032) & (US$ Million) Figure 28. South America Tissue and Organ Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Tissue and Organ Transplantation Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Tissue and Organ Transplantation Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Preservation Solution
  • Immunosuppressive Drugs
  • Tissue Products
Applications
  • Hospital
  • Transplant Centers
  • Others
Companies covered
  • Arthrex
  • Biolife Solutions
  • Discovery Life Sciences
  • Medtronic
  • Stryker Corporation
  • Teva Pharmaceuticals
  • Veloxis Pharmaceutical
  • Zimmer Biomet
  • Abbvie
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tissue and Organ Transplantation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tissue and Organ Transplantation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Tissue and Organ Transplantation Market Dynamics
  1. 2.1 Tissue and Organ Transplantation Industry Trends
  2. 2.2 Tissue and Organ Transplantation Industry Drivers
  3. 2.3 Tissue and Organ Transplantation Industry Opportunities and Challenges
  4. 2.4 Tissue and Organ Transplantation Industry Restraints
3 Tissue and Organ Transplantation Market by Company
  1. 3.1 Global Tissue and Organ Transplantation Company Revenue Ranking in 2025
  2. 3.2 Global Tissue and Organ Transplantation Revenue by Company (2021-2026)
  3. 3.3 Global Tissue and Organ Transplantation Company Ranking (2024-2026)
  4. 3.4 Global Tissue and Organ Transplantation Company Manufacturing Base and Headquarters
  5. 3.5 Global Tissue and Organ Transplantation Company Product Type and Application
  6. 3.6 Global Tissue and Organ Transplantation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Tissue and Organ Transplantation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Tissue and Organ Transplantation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Tissue and Organ Transplantation Market by Type
  1. 4.1 Tissue and Organ Transplantation Type Introduction
  2. 4.1.1 Preservation Solution
  3. 4.1.2 Immunosuppressive Drugs
  4. 4.1.3 Tissue Products
  5. 4.2 Global Tissue and Organ Transplantation Sales Value by Type
  6. 4.2.1 Global Tissue and Organ Transplantation Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Tissue and Organ Transplantation Sales Value by Type (2021-2032)
  8. 4.2.3 Global Tissue and Organ Transplantation Sales Value Share by Type (2021-2032)
5 Tissue and Organ Transplantation Market by Application
  1. 5.1 Tissue and Organ Transplantation Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Transplant Centers
  4. 5.1.3 Others
  5. 5.2 Global Tissue and Organ Transplantation Sales Value by Application
  6. 5.2.1 Global Tissue and Organ Transplantation Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tissue and Organ Transplantation Sales Value by Application (2021-2032)
  8. 5.2.3 Global Tissue and Organ Transplantation Sales Value Share by Application (2021-2032)
6 Tissue and Organ Transplantation Regional Value Analysis
  1. 6.1 Global Tissue and Organ Transplantation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tissue and Organ Transplantation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Tissue and Organ Transplantation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Tissue and Organ Transplantation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tissue and Organ Transplantation Sales Value (2021-2032)
  7. 6.3.2 North America Tissue and Organ Transplantation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Tissue and Organ Transplantation Sales Value (2021-2032)
  10. 6.4.2 Europe Tissue and Organ Transplantation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Tissue and Organ Transplantation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Tissue and Organ Transplantation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Tissue and Organ Transplantation Sales Value (2021-2032)
  16. 6.6.2 South America Tissue and Organ Transplantation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Tissue and Organ Transplantation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Tissue and Organ Transplantation Sales Value Share by Country, 2025 VS 2032
7 Tissue and Organ Transplantation Country-level Value Analysis
  1. 7.1 Global Tissue and Organ Transplantation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tissue and Organ Transplantation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Tissue and Organ Transplantation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Tissue and Organ Transplantation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Tissue and Organ Transplantation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Tissue and Organ Transplantation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Tissue and Organ Transplantation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Arthrex
  2. 8.1.1 Arthrex Company Information
  3. 8.1.2 Arthrex Business Overview
  4. 8.1.3 Arthrex Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Arthrex Tissue and Organ Transplantation Product Portfolio
  6. 8.1.5 Arthrex Recent Developments
  7. 8.2 Biolife Solutions
  8. 8.2.1 Biolife Solutions Company Information
  9. 8.2.2 Biolife Solutions Business Overview
  10. 8.2.3 Biolife Solutions Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biolife Solutions Tissue and Organ Transplantation Product Portfolio
  12. 8.2.5 Biolife Solutions Recent Developments
  13. 8.3 Discovery Life Sciences
  14. 8.3.1 Discovery Life Sciences Company Information
  15. 8.3.2 Discovery Life Sciences Business Overview
  16. 8.3.3 Discovery Life Sciences Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio
  18. 8.3.5 Discovery Life Sciences Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Tissue and Organ Transplantation Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 Stryker Corporation
  26. 8.5.1 Stryker Corporation Company Information
  27. 8.5.2 Stryker Corporation Business Overview
  28. 8.5.3 Stryker Corporation Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Stryker Corporation Tissue and Organ Transplantation Product Portfolio
  30. 8.5.5 Stryker Corporation Recent Developments
  31. 8.6 Teva Pharmaceuticals
  32. 8.6.1 Teva Pharmaceuticals Company Information
  33. 8.6.2 Teva Pharmaceuticals Business Overview
  34. 8.6.3 Teva Pharmaceuticals Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio
  36. 8.6.5 Teva Pharmaceuticals Recent Developments
  37. 8.7 Veloxis Pharmaceutical
  38. 8.7.1 Veloxis Pharmaceutical Company Information
  39. 8.7.2 Veloxis Pharmaceutical Business Overview
  40. 8.7.3 Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio
  42. 8.7.5 Veloxis Pharmaceutical Recent Developments
  43. 8.8 Zimmer Biomet
  44. 8.8.1 Zimmer Biomet Company Information
  45. 8.8.2 Zimmer Biomet Business Overview
  46. 8.8.3 Zimmer Biomet Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zimmer Biomet Tissue and Organ Transplantation Product Portfolio
  48. 8.8.5 Zimmer Biomet Recent Developments
  49. 8.9 Abbvie
  50. 8.9.1 Abbvie Company Information
  51. 8.9.2 Abbvie Business Overview
  52. 8.9.3 Abbvie Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Abbvie Tissue and Organ Transplantation Product Portfolio
  54. 8.9.5 Abbvie Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Tissue and Organ Transplantation Product Portfolio
  60. 8.10.5 Novartis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst